Compare PSNL & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSNL | AI |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2019 | 2020 |
| Metric | PSNL | AI |
|---|---|---|
| Price | $17.08 | $9.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 14 |
| Target Price | $12.20 | ★ $14.00 |
| AVG Volume (30 Days) | 3.4M | ★ 4.3M |
| Earning Date | 05-07-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.58 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $69,648,000.00 | ★ $250,268,000.00 |
| Revenue This Year | $15.34 | N/A |
| Revenue Next Year | $41.46 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.65 | $7.68 |
| 52 Week High | $18.89 | $20.22 |
| Indicator | PSNL | AI |
|---|---|---|
| Relative Strength Index (RSI) | 67.04 | 49.65 |
| Support Level | $7.36 | $8.48 |
| Resistance Level | N/A | $9.75 |
| Average True Range (ATR) | 0.78 | 0.43 |
| MACD | 0.33 | -0.05 |
| Stochastic Oscillator | 72.57 | 19.47 |
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions, namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications; C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications; and C3 Generative AI, which combines the utility of large language models. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.